Position in HIMS
as of Mar 31, 2026
· filed May 8, 2026
Position Value
$5,874,393
-$4,651,567 QoQ
Shares Held
282,967
-12.7% QoQ
Ownership
0.122%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2021
20 quarters on record
Voting authority
Sole 70%
Shared 0%
None 30%
Common Shares in HIMS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Legal & General Group Plc holds $884,912,076 across 47 Drug Manufacturers - Specialty & Generic names. HIMS ranks #14 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
3,650,753 | $431,555,511 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
|
3,872,811 | $116,649,065 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
186,794 | $110,765,104 | |
| 4 | VTRS |
Viatris Inc
|
3,838,534 | $51,858,592 | |
| 5 | NBIX |
Neurocrine Biosciences Inc
|
380,589 | $50,138,793 | |
| 6 | ELAN |
Elanco Animal Health Inc
|
709,808 | $16,985,705 | |
| 7 | ALKS |
Alkermes plc.
|
380,722 | $13,462,329 | |
| 8 | BCRX |
Biocryst Pharmaceuticals Inc
|
1,411,199 | $13,434,613 |
All Filings in HIMS
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $5,874,393 | 282,967 | Shares | Defined | 2026-05-08 | |
| 2025-12-31 | $10,525,960 | 324,175 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $21,808,669 | 384,497 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $19,146,286 | 384,078 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $10,171,404 | 344,210 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $13,837,317 | 572,263 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $3,408,399 | 185,038 | Shares | Defined | 2025-02-28 | |
| 2024-06-30 | $3,387,820 | 167,797 | Shares | Defined | 2025-05-29 | |
| 2024-03-31 | $2,293,922 | 148,282 | Shares | Defined | 2025-05-29 | |
| 2023-12-31 | $1,308,014 | 146,968 | Shares | Defined | 2025-05-29 | |
| 2023-09-30 | $912,226 | 145,028 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $1,123,139 | 119,483 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $609,633 | 61,455 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $375,208 | 58,535 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $326,797 | 58,566 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $250,598 | 55,320 | Shares | Defined | 2022-08-22 | |
| 2022-03-31 | $155,922 | 29,254 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $191,612 | 29,254 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $207,425 | 27,510 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $142,060 | 13,045 | Shares | Defined | 2021-08-12 | |
| No filing history on record for this holder in this stock. | ||||||